Unadjusted analysis | Adjusted analysis | |||||
---|---|---|---|---|---|---|
HR | 95% CI | p | HR | 95% CI | p | |
Baseline variables | ||||||
Age, years | 1 | 1–1.03 | 0.99 | 1 | 1–1.1 | 0.83 |
Years of formal education | 0.9 | 0.9–1 | 0.16 | 0.9 | 0.8–1 | 0.18 |
Presence of comorbidities | 0.6 | 0.5–3.7 | 0.28 | 0.5 | 0.2–1.1 | 0.10 |
SF-36 | 1 | 0.96–1 | 0.08 | 1 | 1–1.02 | 0.79 |
Disease duration, months | 0.9 | 0.8–10.5 | 0.18 | 0.9 | 0.8–1.1 | 0.46 |
Cumulative variables | ||||||
DAS28 | 1.3 | 1.1–1.7 | 0.003 | 1.2 | 0.9–1.6 | 0.40 |
N° of disease flares/patienta | 2.9 | 1.2–5.2 | 0.001 | 2.5 | 1.4–4.5 | 0.003 |
Sustained remission | 0.4 | 0.1–1 | 0.05 | 0.3 | 0.2–2.1 | 0.36 |
N° of DMARDs/patient | 3.1 | 0.1–5.8 | 0.05 | 1.9 | 1.6–5.3 | 0.14 |
Persistence <50%b | 2.7 | 1.3–5.7 | 0.006 | 1.7 | 0.7–4.3 | 0.24 |